ASGE Annual GI Advanced Practice Provider Course (Virtual) - Clinical Case-based Learning (Day Two)

Video Transcription

Video Summary

The Q&A session covered numerous topics related to gastrointestinal disorders, particularly focusing on GERD, Barrett's esophagus, esophageal dysphagia, and PPI therapy. The discussion included the timing and methodology for PH Bravo testing, diagnosing GERD through clinical symptoms versus invasive testing, and considerations for PPI therapy in patients with osteoporosis. The conversation also touched on insurance issues relating to endoluminal antireflux procedures and the use of H2 blockers for nighttime symptoms. Barrett's esophagus was another focus, with participants discussing histologic challenges and surveillance techniques, such as TissueCypher, an AI-driven technology to assess cancer risk. Tobacco’s influence on Barrett's progression, differentiation of dysphagia types, and testing for infections like HPV were other key points. Practical advice was exchanged about transitioning between PPIs and managing GERD symptoms effectively, reflecting the challenges and nuances of gastrointestinal patient care.

Meta Tag

Concept Gastroesophageal Reflux Disease

Concept Proton Pump Inhibitor

Concept Barrett Esophagus

Concept Dysphagia

Concept Bravo pH Testing

Keywords

GERD

Barrett's esophagus

PPI therapy

PH Bravo testing

TissueCypher

esophageal dysphagia

Gastroesophageal Reflux Disease

Proton Pump Inhibitor

Barrett Esophagus

Dysphagia

Bravo pH Testing